Form 4 for TBPH Theravance Biopharma, Inc.
Accepted 2026-06-23 17:49:21 ET · period of report 2026-06-19 · accession 0002012524-26-000006 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-06-23 17:49 | 2026-06-19 | TBPH | Miller Aine | SVP, DEV, HEAD OF IRE OFFICE | A - Grant | $0.00 | +18.8K | 196.1K | +11% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Ordinary Shares | 2026-06-19 | A | A | 18,750 | $0.00 | 196,084 | D | — | — |